Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

BACKGROUND: It is unclear whether people with type 2 diabetes mellitus on insulin monotherapy who do not achieve adequate glycaemic control should continue insulin as monotherapy or can benefit from adding oral glucose‐lowering agents to the insulin therapy. OBJECTIVES: To assess the effects of insu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cochrane Database Syst Rev
Prif Awduron: Vos, Rimke C, van Avendonk, Mariëlle JP, Jansen, Hanneke, Goudswaard, Alexander Nicolaas N, van den Donk, Maureen, Gorter, Kees, Kerssen, Anneloes, Rutten, Guy EHM
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2016
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457595/
https://ncbi.nlm.nih.gov/pubmed/27640062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006992.pub2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg